Cargando…
An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
Fotemustine is a third-generation nitrosourea showing efficacy in various types of tumors such as melanoma and glioma. We reviewed the most important studies on fotemustine treatment in glioma patients analyzing its pharmacological profile and its activity and safety. Fotemustine was used as single...
Autores principales: | Lombardi, Giuseppe, Farina, Patrizia, Della Puppa, Alessandro, Cecchin, Diego, Pambuku, Ardi, Bellu, Luisa, Zagonel, Vittorina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988896/ https://www.ncbi.nlm.nih.gov/pubmed/24800248 http://dx.doi.org/10.1155/2014/698542 |
Ejemplares similares
-
The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014) -
Urine 2-Hydroxyglutarate in Glioma
por: Lombardi, Giuseppe, et al.
Publicado: (2016) -
Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art
por: Bergo, E., et al.
Publicado: (2016) -
Treatment of Malignant Gliomas in Elderly Patients: A Concise Overview of the Literature
por: Farina, Patrizia, et al.
Publicado: (2014) -
Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2014)